The role of ruminant trans fat as a potential nutraceutical in the prevention of cardiovascular disease

Food Research International

Volumn 46, Issue 2, 2012, Pages 460-468

  Wang, Ye ^a   Jacome Sosa, M Miriam ^a   Proctor, Spencer D ^a  

^a MAZANKOWSKI ALBERTA HEART INSTITUTE   (Canada)

Author keywords

Cardiovascular disease; Conjugated linoleic acid; Dyslipidemia; Metabolic syndrome; Ruminant trans fat; Vaccenic acid

Indexed keywords

CARDIO-VASCULAR DISEASE; CONJUGATED LINOLEIC ACID; DYSLIPIDEMIAS; METABOLIC SYNDROMES; TRANS FATS; VACCENIC ACID;

DISEASES; MAMMALS; VEGETABLE OILS;

LINOLEIC ACID;

ANIMALIA; BOVIDAE;

EID: 84858008442     PISSN: 09639969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodres.2011.08.019     Document Type: Article

References (85)

1. Aldai N., Dugan M.E., Kramer J.K., Mir P.S., McAllister T.A. Nonionophore antibiotics do not affect the trans-18:1 and conjugated linoleic acid composition in beef adipose tissue. Journal of Animal Science 2008, 86(12):3522-3532.
2. Arbones-Mainar J.M., Navarro M.A., Acin S., Guzman M.A., Arnal C., Surra J.C., Carnicer R., Roche H.M., Osada J. Trans-10, cis-12- and cis-9, trans-11-conjugated linoleic acid isomers selectively modify HDL-apolipoprotein composition in apolipoprotein E knockout mice. Journal of Nutrition 2006, 136(2):353-359.
3. Arbones-Mainar J.M., Navarro M.A., Guzman M.A., Arnal C., Surra J.C., Acin S., Carnicer R., Osada J., Roche H.M. Selective effect of conjugated linoleic acid isomers on atherosclerotic lesion development in apolipoprotein E knockout mice. Atherosclerosis 2006, 189(2):318-327.
4. Aro A., Mannisto S., Salminen I., Ovaskainen M.L., Kataja V., Uusitupa M. Inverse association between dietary and serum conjugated linoleic acid and risk of breast cancer in postmenopausal women. Nutrition and Cancer 2000, 38(2):151-157.
5. Banni S. Conjugated linoleic acid metabolism. Current Opinion in Lipidology 2002, 13(3):261-266.
6. Bansal S., Buring J.E., Rifai N., Mora S., Sacks F.M., Ridker P.M. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007, 298(3):309-316.
7. -/- mice. Journal of Nutrition 2010, 140(1):18-24.
8. Bauchart D., Roy A., Lorenz S., Chardigny J.M., Ferlay A., Gruffat D., Sebedio J.L., Chilliard Y., Durand D. Butters varying in trans 18:1 and cis-9, trans-11 conjugated linoleic acid modify plasma lipoproteins in the hypercholesterolemic rabbit. Lipids 2007, 42(2):123-133.
9. Bendsen N.T., Christensen R., Bartels E.M., Astrup A. Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: A systematic review and meta-analysis of cohort studies. European Journal of Clinical Nutrition 2011, 65(7):773-783.
10. Biscetti F., Straface G., Pitocco D., Zaccardi F., Ghirlanda G., Flex A. Peroxisome proliferator-activated receptors and angiogenesis. Nutrition, Metabolism, and Cardiovascular Diseases 2009, 19(11):751-759.
11. Blewett H.J., Gerdung C.A., Ruth M.R., Proctor S.D., Field C.J. Vaccenic acid favourably alters immune function in obese JCR:LA-cp rats. British Journal of Nutrition 2009, 102(4):526-536.
12. Boeckaert C., Vlaeminck B., Fievez V., Maignien L., Dijkstra J., Boon N. Accumulation of trans C18:1 fatty acids in the rumen after dietary algal supplementation is associated with changes in the Butyrivibrio community. Applied and Environmental Microbiology 2008, 74(22):6923-6930.
13. Brouwer I.A., Wanders A.J., Katan M.B. Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans-A quantitative review. PloS One 2010, 5(3):e9434.
14. Brown J.M., McIntosh M.K. Conjugated linoleic acid in humans: Regulation of adiposity and insulin sensitivity. Journal of Nutrition 2003, 133(10):3041-3046.
15. Brown J.D., Plutzky J. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. Circulation 2007, 115(4):518-533.
16. Chardigny J.M., Destaillats F., Malpuech-Brugere C., Moulin J., Bauman D.E., Lock A.L., Barbano D.M., Mensink R.P., Bezelgues J.B., Chaumont P., Combe N., Cristiani I., Joffre F., German J.B., Dionisi F., Boirie Y., Sebedio J.L. Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. American Journal of Clinical Nutrition 2008, 87(3):558-566.
17. Craig-Schmidt M.C. World-wide consumption of trans fatty acids. Atherosclerosis Supplements 2006, 7(2):1-4.
18. Dane-Stewart C.A., Watts G.F., Pal S., Chan D., Thompson P., Hung J., Mamo J.C. Effect of atorvastatin on apolipoprotein B48 metabolism and low-density lipoprotein receptor activity in normolipidemic patients with coronary artery disease. Metabolism 2003, 52(10):1279-1286.
19. Desroches S., Chouinard P.Y., Galibois I., Corneau L., Delisle J., Lamarche B., Couture P., Bergeron N. Lack of effect of dietary conjugated linoleic acids naturally incorporated into butter on the lipid profile and body composition of overweight and obese men. American Journal of Clinical Nutrition 2005, 82(2):309-319.
20. Elias S.L., Innis S.M. Bakery foods are the major dietary source of trans-fatty acids among pregnant women with diets providing 30 percent energy from fat. Journal of the American Dietetic Association 2002, 102(1):46-51.
21. Freiberg J.J., Tybjaerg-Hansen A., Jensen J.S., Nordestgaard B.G. Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA 2008, 300(18):2142-2152.
22. Hulshof K.F., van Erp-Baart M.A., Anttolainen M., Becker W., Church S.M., Couet C., Hermann-Kunz E., Kesteloot H., Leth T., Martins I., Moreiras O., Moschandreas J., Pizzoferrato L., Rimestad A.H., Thorgeirsdottir H., van Amelsvoort J.M., Aro A., Kafatos A.G., Lanzmann-Petithory D., van Poppel G. Intake of fatty acids in western Europe with emphasis on trans fatty acids: The TRANSFAIR Study. European Journal of Clinical Nutrition 1999, 53(2):143-157.
23. Innis S.M. Trans fatty intakes during pregnancy, infancy and early childhood. Atherosclerosis Supplements 2006, 7(2):17-20.
24. Iwakiri Y., Sampson D.A., Allen K.G. Suppression of cyclooxygenase-2 and inducible nitric oxide synthase expression by conjugated linoleic acid in murine macrophages. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2002, 67(6):435-443.
25. Jacome-Sosa M.M., Lu J., Wang Y., Ruth M.R., Wright D.C., Reaney M.J., Shen J., Field C.J., Vine D.F., Proctor S.D. Increased hypolipidemic benefits of cis-9, trans-11 conjugated linoleic acid in combination with trans-11 vaccenic acid in a rodent model of the metabolic syndrome, the JCR:LA-cp rat. Nutrition Metabolism (London) 2010, 7:60.
26. Jakobsen M.U., Bysted A., Andersen N.L., Heitmann B.L., Hartkopp H.B., Leth T., Overvad K., Dyerberg J. Intake of ruminant trans fatty acids in the Danish population aged 1-80 years. European Journal of Clinical Nutrition 2006, 60(3):312-318.
27. Kliewer S.A., Sundseth S.S., Jones S.A., Brown P.J., Wisely G.B., Koble C.S., Devchand P., Wahli W., Willson T.M., Lenhard J.M., Lehmann J.M. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proceedings of the National Academy of Sciences of the United States of America 1997, 94(9):4318-4323.
28. Krauss R.M. Dense low density lipoproteins and coronary artery disease. The American Journal of Cardiology 1995, 75(6):53B-57B.
29. Kritchevsky D., Tepper S.A., Wright S., Czarnecki S.K., Wilson T.A., Nicolosi R.J. Conjugated linoleic acid isomer effects in atherosclerosis: growth and regression of lesions. Lipids 2004, 39(7):611-616.
30. Kuhnt K., Kraft J., Vogelsang H., Eder K., Kratzsch J., Jahreis G. Dietary supplementation with trans-11- and trans-12-18: 1 increases cis-9, trans-11-conjugated linoleic acid in human immune cells, but without effects on biomarkers of immune function and inflammation. British Journal of Nutrition 2007, 97(6):1196-1205.
31. Langsted A., Freiberg J.J., Nordestgaard B.G. Fasting and nonfasting lipid levels: Influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 2008, 118(20):2047-2056.
32. LeDoux M., Laloux L., Fontaine J.J., Carpentier Y.A., Chardigny J.M., Sebedio J.L. Rumenic acid significantly reduces plasma levels of LDL and small dense LDL cholesterol in hamsters fed a cholesterol- and lipid-enriched semi-purified diet. Lipids 2007, 42(2):135-141.
33. Libby P. Inflammation and cardiovascular disease mechanisms. American Journal of Clinical Nutrition 2006, 83(2):456S-460S.
34. Lock A.L., Bauman D.E. Modifying milk fat composition of dairy cows to enhance fatty acids beneficial to human health. Lipids 2004, 39(12):1197-1206.
35. Lock A.L., Horne C.A., Bauman D.E., Salter A.M. Butter naturally enriched in conjugated linoleic acid and vaccenic acid alters tissue fatty acids and improves the plasma lipoprotein profile in cholesterol-fed hamsters. Journal of Nutrition 2005, 135(8):1934-1939.
36. Lopez-Garcia E., Schulze M.B., Meigs J.B., Manson J.E., Rifai N., Stampfer M.J., Willett W.C., Hu F.B. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. Journal of Nutrition 2005, 135(3):562-566.
37. Malpuech-Brugere C., Verboeket-van de Venne W.P., Mensink R.P., Arnal M.A., Morio B., Brandolini M., Saebo A., Lassel T.S., Chardigny J.M., Sebedio J.L., Beaufrere B. Effects of two conjugated linoleic acid isomers on body fat mass in overweight humans. Obesity Research 2004, 12(4):591-598.
38. Meijer G.W., van Tol A., van Berkel T.J., Weststrate J.A. Effect of dietary elaidic versus vaccenic acid on blood and liver lipids in the hamster. Atherosclerosis 2001, 157(1):31-40.
39. Mendis S., Cruz-Hernandez C., Ratnayake W.M. Fatty acid profile of Canadian dairy products with special attention to the trans-octadecenoic acid and conjugated linoleic acid isomers. Journal of AOAC International 2008, 91(4):811-819.
40. Mensink R.P. Metabolic and health effects of isomeric fatty acids. Current Opinion in Lipidology 2005, 16(1):27-30.
41. Micha R., Mozaffarian D. Trans fatty acids: Effects on metabolic syndrome, heart disease and diabetes. Nature Reviews. Endocrinology 2009, 5(6):335-344.
42. Mitchell P.L., Langille M.A., Currie D.L., McLeod R.S. Effect of conjugated linoleic acid isomers on lipoproteins and atherosclerosis in the Syrian Golden hamster. Biochimica et Biophysica Acta 2005, 1734(3):269-276.
43. Motard-Belanger A., Charest A., Grenier G., Paquin P., Chouinard Y., Lemieux S., Couture P., Lamarche B. Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. American Journal of Clinical Nutrition 2008, 87(3):593-599.
44. Mozaffarian D., Clarke R. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. European Journal of Clinical Nutrition 2009, 63(Suppl 2):S22-S33.
45. Mozaffarian D., Pischon T., Hankinson S.E., Rifai N., Joshipura K., Willett W.C., Rimm E.B. Dietary intake of trans fatty acids and systemic inflammation in women. American Journal of Clinical Nutrition 2004, 79(4):606-612.
46. Murakami K., Ide T., Suzuki M., Mochizuki T., Kadowaki T. Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha. Biochemical and Biophysical Research Communications 1999, 260(3):609-613.
47. Najib J. Fenofibrate in the treatment of dyslipidemia: A review of the data as they relate to the new suprabioavailable tablet formulation. Clinical Therapeutics 2002, 24(12):2022-2050.
48. Naumann E., Carpentier Y.A., Saebo A., Lassel T.S., Chardigny J.M., Sebedio J.L., Mensink R.P. Cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) do not affect the plasma lipoprotein profile in moderately overweight subjects with LDL phenotype B. Atherosclerosis 2006, 188(1):167-174.
49. Nishida C., Uauy R. WHO Scientific Update on health consequences of trans fatty acids: Introduction. European Journal of Clinical Nutrition 2009, 63(Suppl 2):S1-S4.
50. Oomen C.M., Ocke M.C., Feskens E.J., van Erp-Baart M.A., Kok F.J., Kromhout D. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: A prospective population-based study. Lancet 2001, 357(9258):746-751.
51. Palmquist D.L., Lock A.L., Shingfield K.J., Bauman D.E. Biosynthesis of conjugated linoleic acid in ruminants and humans. Advances in Food and Nutrition Research 2005, 50:179-217.
52. Precht D. Variation of trans fatty acids in milk fats. Zeitschrift für Ernährungswissenschaft 1995, 34(1):27-29.
53. Proctor S.D., Kelly S.E., Stanhope K.L., Havel P.J., Russell J.C. Synergistic effects of conjugated linoleic acid and chromium picolinate improve vascular function and renal pathophysiology in the insulin-resistant JCR:LA-cp rat. Diabetes, Obesity & Metabolism 2007, 9(1):87-95.
54. Proctor S.D., Vine D.F., Mamo J.C. Arterial retention of apolipoprotein B(48)- and B(100)-containing lipoproteins in atherogenesis. Current Opinion in Lipidology 2002, 13(5):461-470.
55. Raff M., Tholstrup T., Basu S., Nonboe P., Sorensen M.T., Straarup E.M. A diet rich in conjugated linoleic acid and butter increases lipid peroxidation but does not affect atherosclerotic, inflammatory, or diabetic risk markers in healthy young men. Journal of Nutrition 2008, 138(3):509-514.
56. Ramakers J.D., Plat J., Sebedio J.L., Mensink R.P. Effects of the individual isomers cis-9,trans-11 vs. trans-10,cis-12 of conjugated linoleic acid (CLA) on inflammation parameters in moderately overweight subjects with LDL-phenotype B. Lipids 2005, 40(9):909-918.
57. Reddick R.L., Zhang S.H., Maeda N. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arteriosclerosis Thrombosis 1994, 14(1):141-147.
58. Rego O.A., Alves S.P., Antunes L.M., Rosa H.J., Alfaia C.F., Prates J.A., Cabrita A.R., Fonseca A.J., Bessa R.J. Rumen biohydrogenation-derived fatty acids in milk fat from grazing dairy cows supplemented with rapeseed, sunflower, or linseed oils. Journal of Dairy Science 2009, 92(9):4530-4540.
59. Ringseis R., Wen G., Saal D., Eder K. Conjugated linoleic acid isomers reduce cholesterol accumulation in acetylated LDL-induced mouse RAW264.7 macrophage-derived foam cells. Lipids 2008, 43(10):913-923.
60. Riserus U., Vessby B., Arnlov J., Basu S. Effects of cis-9, trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. American Journal of Clinical Nutrition 2004, 80(2):279-283.
61. Roy A. Butters rich either in trans-10-C18:1 or in trans-11-C18:1 plus cis-9, trans-11 CLA differentially affect plasma lipids and aortic fatty streak in experimental atherosclerosis in rabbits. Animal 2007, 1:10.
62. Ruth M.R., Wang Y., Yu H.M., Goruk S.D., J., R.M., Proctor S.D., Vine D.F., Field C.J. Vaccenic and elaidic acid modify plasma and splenocyte membrane phospholipids and mitogen-stimulated cytokine production in obese insulin resistant JCR: LA-cp rats. Nutrients 2010, 2:17.
63. Sofi F., Buccioni A., Cesari F., Gori A.M., Minieri S., Mannini L., Casini A., Gensini G.F., Abbate R., Antongiovanni M. Effects of a dairy product (pecorino cheese) naturally rich in cis-9, trans-11 conjugated linoleic acid on lipid, inflammatory and haemorheological variables: A dietary intervention study. Nutrition, Metabolism, and Cardiovascular Diseases 2010, 20(2):117-124.
64. Stachowska E., Dolegowska B., Dziedziejko V., Rybicka M., Kaczmarczyk M., Bober J., Rac M., Machalinski B., Chlubek D. Prostaglandin E2 (PGE2) and thromboxane A2 (TXA2) synthesis is regulated by conjugated linoleic acids (CLA) in human macrophages. Journal of Physiology and Pharmacology 2009, 60(1):77-85.
65. Taniguchi M., Utsugi T., Oyama K., Mannen H., Kobayashi M., Tanabe Y., Ogino A., Tsuji S. Genotype of stearoyl-coA desaturase is associated with fatty acid composition in Japanese Black cattle. Mammalian Genome 2004, 15(2):142-148.
66. Tardy A.L., Giraudet C., Rousset P., Rigaudiere J.P., Laillet B., Chalancon S., Salles J., Loreau O., Chardigny J.M., Morio B. Effects of trans MUFA from dairy and industrial sources on muscle mitochondrial function and insulin sensitivity. Journal of Lipid Research 2008, 49(7):1445-1455.
67. Tholstrup T., Raff M., Basu S., Nonboe P., Sejrsen K., Straarup E.M. Effects of butter high in ruminant trans and monounsaturated fatty acids on lipoproteins, incorporation of fatty acids into lipid classes, plasma C-reactive protein, oxidative stress, hemostatic variables, and insulin in healthy young men. American Journal of Clinical Nutrition 2006, 83(2):237-243.
68. Tholstrup T., Raff M., Straarup E.M., Lund P., Basu S., Bruun J.M. An oil mixture with trans-10, cis-12 conjugated linoleic acid increases markers of inflammation and in vivo lipid peroxidation compared with cis-9, trans-11 conjugated linoleic acid in postmenopausal women. Journal of Nutrition 2008, 138(8):1445-1451.
69. -/- mouse by conjugated linoleic acid. Biochemical Society Transactions 2003, 31(Pt 5):1075-1079.
70. Tricon S., Burdge G.C., Jones E.L., Russell J.J., El-Khazen S., Moretti E., Hall W.L., Gerry A.B., Leake D.S., Grimble R.F., Williams C.M., Calder P.C., Yaqoob P. Effects of dairy products naturally enriched with cis-9, trans-11 conjugated linoleic acid on the blood lipid profile in healthy middle-aged men. American Journal of Clinical Nutrition 2006, 83(4):744-753.
71. Tricon S., Burdge G.C., Kew S., Banerjee T., Russell J.J., Jones E.L., Grimble R.F., Williams C.M., Yaqoob P., Calder P.C. Opposing effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid on blood lipids in healthy humans. American Journal of Clinical Nutrition 2004, 80(3):614-620.
72. Turpeinen A.M., Mutanen M., Aro A., Salminen I., Basu S., Palmquist D.L., Griinari J.M. Bioconversion of vaccenic acid to conjugated linoleic acid in humans. American Journal of Clinical Nutrition 2002, 76(3):504-510.
73. Tyburczy C., Major C., Lock A.L., Destaillats F., Lawrence P., Brenna J.T., Salter A.M., Bauman D.E. Individual trans octadecenoic acids and partially hydrogenated vegetable oil differentially affect hepatic lipid and lipoprotein metabolism in golden Syrian hamsters. Journal of Nutrition 2009, 139(2):257-263.
74. Valeille K., Ferezou J., Amsler G., Quignard-Boulange A., Parquet M., Gripois D., Dorovska-Taran V., Martin J.C. A cis-9, trans-11-conjugated linoleic acid-rich oil reduces the outcome of atherogenic process in hyperlipidemic hamster. American Journal of Physiology. Heart and Circulatory Physiology 2005, 289(2):H652-H659.
75. Valeille K., Ferezou J., Parquet M., Amsler G., Gripois D., Quignard-Boulange A., Martin J.C. The natural concentration of the conjugated linoleic acid, cis-9, trans-11, in milk fat has antiatherogenic effects in hyperlipidemic hamsters. Journal of Nutrition 2006, 136(5):1305-1310.
76. Valeille K., Gripois D., Blouquit M.F., Souidi M., Riottot M., Bouthegourd J.C., Serougne C., Martin J.C. Lipid atherogenic risk markers can be more favourably influenced by the cis-9, trans-11-octadecadienoate isomer than a conjugated linoleic acid mixture or fish oil in hamsters. British Journal of Nutrition 2004, 91(2):191-199.
77. Voorrips L.E., Brants H.A., Kardinaal A.F., Hiddink G.J., van den Brandt P.A., Goldbohm R.A. Intake of conjugated linoleic acid, fat, and other fatty acids in relation to postmenopausal breast cancer: The Netherlands Cohort Study on Diet and Cancer. American Journal of Clinical Nutrition 2002, 76(4):873-882.
78. Wang Y., Jacome-Sosa M.M., Ruth M.R., Goruk S.D., Reaney M.J., Glimm D.R., Wright D.C., Vine D.F., Field C.J., Proctor S.D. Trans-11 vaccenic acid reduces hepatic lipogenesis and chylomicron secretion in JCR:LA-cp rats. Journal of Nutrition 2009, 139(11):2049-2054.
79. Wang Y., Jacome-Sosa M.M., Yu H.M., Field C.J., Vine D.F., Proctor S.D. Dietary trans-11 vaccenic acid increases intestinal PPAR alpha and gamma expression in the JCR:LA-cp rat. Atherosclerosis Supplements 2010, 1:2.
80. Wang Y., Lu J., Ruth M.R., Goruk S.D., Reaney M.J., Glimm D.R., Vine D.F., Field C.J., Proctor S.D. Trans-11 vaccenic acid dietary supplementation induces hypolipidemic effects in JCR:LA-cp rats. Journal of Nutrition 2008, 138(11):2117-2122.
81. Willett W.C., Stampfer M.J., Manson J.E., Colditz G.A., Speizer F.E., Rosner B.A., Sampson L.A., Hennekens C.H. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 1993, 341(8845):581-585.
82. Wilson T.A., Nicolosi R.J., Saati A., Kotyla T., Kritchevsky D. Conjugated linoleic acid isomers reduce blood cholesterol levels but not aortic cholesterol accumulation in hypercholesterolemic hamsters. Lipids 2006, 41(1):41-48.
83. Wolff R.L., Combe N.A., Destaillats F., Boue C., Precht D., Molkentin J., Entressangles B. Follow-up of the delta4 to delta16 trans-18:1 isomer profile and content in French processed foods containing partially hydrogenated vegetable oils during the period 1995-1999. Analytical and nutritional implications. Lipids 2000, 35(8):815-825.
84. Wolff R.L., Precht D. Reassessment of the contribution of bovine milk fats to the trans-18:1 isomeric acid consumption by European populations. Additional data for rumenic (cis-9,trans-11 18:2) acid. Lipids 2002, 37(12):1149-1150.
85. Yu Y., Correll P.H., Vanden Heuvel J.P. Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: Evidence for a PPAR gamma-dependent mechanism. Biochimica et Biophysica Acta 2002, 1581(3):89-99.